Summary The MCF-7 doxorubicin-resistant cell line MCF-7/Dox has been used extensively for studies of the multidrug resistance phenomenon. Using fluorescence-activated cell sorting (FACS), these cells were separated into two populations on the basis of rhodamine 123 (R123) accumulation. We designated these as low Pglycoprotein (LP-gp) and high P-gp (HP-gp) 
Multidrug resistance (MDR) caused by overexpression of the membrane ATPase pump P-glycoprotein (P-gp) can be induced in cells in culture by exposure to cytotoxic agents at progressively increasing concentrations (Riordan and Ling, 1979; Kartner et al., 1983a,b; Chan et al., 1988) . In vitro levels of resistance to the inducing agent of greater than 1000-fold compared with wild-type cells have been achieved (Beck et al., 1979; Shen et al., 1986a) . P-gps are coded for by the MDR gene family, the number of members of which varies between species. Humans possess two MDR genes, MDR] and MDR2 (Chin et al., 1989; Ng et al., 1989) . Of these, only MDRJ codes for a P-gp (P-gp 1) that can confer a drug resistance phenotype when transfected into drug-sensitive cells (Ueda et al., 1987; Choi et al., 1991) . Multidrug-resistant cells, particularly those which display high levels of resistance, often possess an increased copy number of the MDR] gene Fairchild et al., 1987; Endicott and Ling, 1989; Van der Bliek and Borst, 1989) . However, in clinical samples resistance levels due to P-gp expression appear to be lower than those induced in vitro, and gene amplification has rarely been observed (Efferth and Osieka, 1993) . Additionally, cells selected in vitro for lower levels of drug resistance do not show MDRJ gene amplification (Shen et al., 1986b; Kohno et al., 1994) .
One enzyme system that seems to be an important posttranslational regulator of P-gp activity via phosphorylation is protein kinase C (PKC). The phosphorylation state and activity of P-gp can be augmented by PKC activators, such as tumour-promoting phorbol esters (Chambers et al., 1990 (Chambers et al., , 1992 Ma et al., 1991) and inhibited by agents such as staurosporine (Chambers et al., 1990 (Chambers et al., , 1992 Chaudhary and Roninson, 1992; Bates et al., 1993) . Of the PKC isozymes, only PKC-a has to date been identified as important in the post-translational regulation of P-gp activity (Yu et al., 1991;  Ahmad and Glazer, 1993; Ahmad et al., 1994) . We analysed PKC expression levels and subcellular distribution to evaluate possible candidates that may have a role to play in phosphorylation and regulation of P-gp.
Doxorubicin-resistant MCF-7 cells (MCF-7/Dox) have been used frequently as a model for the study of MDR resistance and its modulation. These cells were initially derived by exposure of the MCF-7 breast carcinoma cell line to increasing concentrations of doxorubicin . MCF-7/Dox cells show a 192-fold increase in resistance towards doxorubicin and cross-resistance to a variety of other drugs such as actinomycin D and vinblastine . The resistance phenotype is stable for 3 months when the cells are maintained in drug-free medium. It is not clear how P-gp-mediated drug resistance in these cells is regulated at the genetic level and which molecular events are required to maintain it. The cells are characterised by a number of biochemical changes when compared with their wild-type counterparts, in particular elevated expression of Pgp, amplification of the MDR gene Fairchild et al., 1987) , augmented expression of glutathione S-transferase , and increased expression of PKC (Fine et al., 1988) .
During a study to validate P-gp activity using rhodamine-123 (R123) accumulation and efflux we detected the presence of two cell populations in our culture of MCF-7/Dox cells with differing rates of R123 efflux. We sorted these cells into two lines with different P-gp levels and used them to explore mechanisms of MDRJ and 2 gene regulation and the involvement of PKC isoenzymes in the regulation of P-gp activity.
Flow cytometric analysis of rhodamine (RJ23) accumulation and retention Cells (1 x 106) were allowed to attach to 55 mm Petri dishes (Falcon) for 1.5 h in 3 ml of complete medium. Following cell attachment the medium was replaced with 5 ml of serumfree medium and cells were cultured for 10 or 20 min with 1.66 jiM R123, After this incubation period cells were washed with phosphate-buffered saline (PBS) and either harvested or treated with 5 ml of fresh medium and maintained in culture for 1.5 h to allow for dye efflux to occur before cell harvest. Cells were detached by treatment with trypsin-EDTA at 4°C, washed and resuspended in 1 ml of ice-cold PBS, and 10 jug ml-' propidium iodide (PI) was added. Flow cytometric analysis of the cells was carried out using a Becton Dickinson FACScan flow cytometer with excitation wavelength set at 488 nm. R123 fluorescence was collected after passage through a 515-545 nm bandpass filter, and PI fluorescence was collected after passing through a 546-606 nm bandpass filter. Single and multiparameter measurements of R123 forward angle, side angle scatter, R123 and PI fluorescence were collected for 10 000 events. Fluorescence data were collected on a four decade log scale and analysed using Lysis 2 software. Only R123 fluorescence from viable cells (i.e. PI-excluding cells) were evaluated.
The effects of P-gp inhibitors on R123 accumulation and efflux were studied by co-incubating cells with R123 and inhibitor (5 jiM) for 10 min. The efflux of R123 over a 1.5 h period was determined by incubating the cells in R123-free medium but containing the inhibitor (5 gM). and hybridised to probes pHDR5A (Ueda et al., 1987) and MDR2pvuII (Currier et al., 1992) , which detected MDRJ/2 and MDR2 gene fragments respectively. Hybridisation was performed as previously described for the use of these probes in Northern analysis for RNA expression (Gant et al., 1991 (Gant et al., , 1992 . The blots were washed with 0.1 x SSC/0. 1 %SDS for 1 h at 42°C. Gels were visualised and quantitated using one specific band for MDR] and MDR2 as described below for quantitation of the RT-PCR gels.
Determination of cytotoxicity Cells were seeded at 2 x 104 per 35-mm-diameter dish in 3 ml of medium. After a 4 h incubation period to allow cell attachment various concentrations of doxorubicin were added. The toxicity of each concentration was determined in duplicate dishes. The cells were left for 96 h (four doubling times) and medium and doxorubicin was replenished at 48 h. The cells were trypsinised and counted using a Coulter Counter model ZM (Coulter Electronics, Luton, UK). Growth inhibition was calculated as a percentage of drug-free control. The concentration of doxorubicin causing a 50% growth reduction (ICso) was determined for each cell line.
RT-PCR analysis of gene expression RT-PCR was carried out using internal RNA standards. The internal standard was a modified sequence of the cellular RNA being amplified and which contained the same primer sites. The modification made the internal standard sequence slightly longer by duplication of a piece of sequence between the primer sites. Details of primer construction are given below. In the analysis between 20 and 300 ng of cellular RNA was mixed with between 0.005 and 20 pg of the internal standard RNA in a final reaction volume of 10 pl containing 20 mM Tris-HCl, pH 8.4, and 50 mM potassium chloride, Mg2+ 2.5 mM, RNAsin (Promega) 1 U ul-', MMLV-reverse transcriptase (Gibco/BRL) 10 U yl-', dNTP 1 mM, hexamers (Pharmacia) approximately 15 pmol ,l-' and dithiothreitol 1 mM. Hexamers were annealed at 23°C for 10 min, products extended at 420C for 45 min and the reaction terminated by heating to 99°C before being quick chilled to 4°C (Futscher et al., 1993) . The PCR stage was carried out by the addition of reagents (made as a master mix) to concentrations of 20 mMTris-HCl, pH 8.4, 50 mM potassium chloride, 2.5 mM Mg2+, 1 pmol il-' sense and antisense primer (see below for primers) of which 0.01 pmol pl-' sense primer was end labelled with 33P, 0.05% w-I detergent (Gibcol/BRL) and 2.5 U Taq DNA polymerase in a final volume of 20 Ml. The nucleotides were derived entirely from the original reverse transcriptase reaction and so were at a final concentration of 0.5 mm for each nucleotide. PCR was carried out for 28 cycles at an annealing temperature of 550C for MDRI and 59°C for MDR2. Denaturation was at 95°C for 1 min in each cycle except the first in which it was extended to 5 min. The extension time was 2 min (72°C) in each cycle except the last in which it was extended to 5 min. Annealing was for 2 min in each cycle. For each set of reactions a negative control was run that did not contain RNA. PCR products were not detectable in this reaction.
After PCR a 5 Mil aliquot of each reaction was analysed on an 8% non-denaturing gel. After drying, the gel was exposed in a phosphorimager screen (Molecular Dynamics, Sunnyvale, CA, USA). Expression of each RNA was analysed by volume analysis with a local background using Image Quant 3.3 software (Molecular Dynamics).
To calculate absolute RNA concentrations five reactions for each RNA sample were performed using the same amount of cellular RNA in each, but an increasing amount of the internal standard RNA. The ratio of the PCR band volume from cellular RNA over band volume due to internal standard RNA was plotted as a double loge plot against the amount of the internal standard. The amount of internal standard and cellular RNA are equal when the ratio of these bands is 1 (log, = 0). Care was taken to ensure that the experimental data spanned a ratio of 1 so that linearity to a ratio of one was not assumed. For each sample three analyses were performed. Kinetics and reaction characteristics are published in Zhang et al. (1996) .
Construction of the MDR internal standard RNAs The piece of the MDR] gene chosen for RT-PCR assay was the region between bases 1991 (numbered from the adenosine of the translation initiation codon) and 2416. The region was amplified using primers 5'-AAAAAGATCAACTCGTAG-GAGTG-3' (sense strand) and 5'-GCACAAAATACAC-CAACAA-3' (antisense strand). The internal standard was constructed by duplication of the region between base 2040 (HindlII site) and 2085 by PCR of this region using the sense primer described above and an antisense primer spanning bases 2065 to 2085 which had a HindIII site added at the 5' end. Following PCR the product was cut with HindIII and inserted into the HindIII site of the assay sequence. Thus the internal standard was 51 bp longer than the assay region allowing for inclusion of a second HindIII site. The whole construct was contained in the pGem T vector (Promega) and sequenced using a primer to the SP6 promoter region. The plasmid was linearised using PstI before transcription of sense RNA from the T7 promoter.
Construction of the MDR2 internal standard control was very similar to that of MDR]. The area chosen for RT-PCR assay spanned bases 1343 (numbered from the adenosine of the translation initiation codon) and 1570. The region was amplified using primers 5'-TGATGAGGGCACAATTAA-CA-3' (sense) and 5'-GTGTCAAATTTCTGTGGAAT-3' (antisense). The internal standard was made by duplication of the sequence between bases 1408 and 1494 (NcoI site) using the antisense primer above and a primer between bases 1408 and 1427 which had an NcoI site added to the 5' end. The PCR Biochemical regulation of P-glycoprotein-mediated drug resistance R Davies et at g 309 product was cut with Ncol and inserted into the analysis region at the NcoI site. The whole construct was contained in the pGEM4Z plasmid (Promega). The insert was sequenced using a primer to the SP6 promoter and linearised using PstI before transcription of sense RNA from the SP6 promoter.
Following transcription the size and integrity of the RNA was checked on a denaturing agarose gel and concentration assessed by determining optical absorbance at 260 nm. The molecular weight of the construct was determined, taking into account the additional sequence derived from the vector. The RNA was aliquoted and stored at -80°C before use.
Western blot analysis of PKC isozymes Cells were grown on 140 mm Petri dishes. When they approached confluence cytosolic, particulate (membrane) and nuclear fractions were prepared as previously described (Greif et al., 1992) with some modifications (Stanwell et al., 1994) . The protein content of each sample was determined by the method of Bradford, (1976) .
Western blot analysis was performed as described previously (Stanwell et al., 1994) that the low R123 fluorescence cells had the higher P-gp content. Likewise, the high R123 fluorescence cells expressed the lower P-gp level. Thus, R123 accumulation was inversely correlated with P-gp content (Figure 3) . Furthermore, the sorted high R123 fluorescence cell line expressed the lower Pgp levels ( Figure 3 ) and will therefore be referred to in the following text as LP-gp (low P-gp) cells. The sorted R123 low fluorescence cells expressed higher P-gp levels and will therefore be referred to as HP-gp (high P-gp) cells. As PKC-xc has been shown to play a role in the regulation of P-gp activity (Yu et al., 1991; Ahmad and Glazer, 1993; Ahmad et al., 1994 ) levels and subcellular distribution of PKC isozymes were examined. All three MCF-7 doxorubicinresistant cell lines expressed PKC-a, -C, -e and -6 ( Figure 6 and Figure 6 . MCF-7/WT cells ( Figure 6 ). Expression of PKC-a was undetectable in MCF-7/WT cells but it was found at identical levels in LP-gp and HP-gp cells. Most of the enzyme was localised in the cytosol, whereas 1 % was associated with each of the membrane and nuclear compartments. Overall expression of PKC-e and PKC-C in both LP-gp and HP-gp cells was decreased compared with MCF-7/WT cells (Table II) . This decrease was mainly accounted for by a loss of cytosolic enzyme. However, in LP-gp and HP-gp cells PKC-a was located to a greater extent in the nuclear and membrane fractions compared with MCF-7/WT cells. PKC-0 was not detectable in MCF-7/WT cells, but abundant in the resistant cells. In this case isozyme distribution was relatively homogeneous between the subcellular fractions.
Discussion
The multidrug-resistant MCF-7/Dox cell line was originally derived in 1986 and has been widely used for studies of P-gp . The results presented above show that our MCF-7/Dox cells comprised two subclones that were separable according to their ability to efflux R123. The presence of two clones in the MCF-7/Dox cells has been shown previously by MRK-16 antibody binding, but was not discussed (Yu et al., 1991) . In contrast another very recent analysis with MRK16 found only one cell clone (Molinari et al., 1994) .
In the work outlined above we present six separate pieces of evidence that suggest differences in P-gp expression levels between LP-gp and HP-gp cells that constitute the MCF-7/ Dox cell line: (i) they accumulate and retain R123 differently; (ii) they demonstrate different levels of immunoreactivity with the anti-P-gpl antibody MRK-16; (iii) they exhibit different degrees of MDRJ and MDR2 gene amplification; (iv) they display different sensitivity towards doxorubicin; (v) they possess different levels of MDRI and MDR2 mRNA; and (vi) (Morrow et al., 1992; Madden et al., 1993) . These data suggest that regulation of mRNA level in the LP-gp and HP-gp cells may occur to a greater degree at the transcriptional rather than post-transcriptional level.
Correlation of the results obtained by fluorescence analysis using the MRK-16 antibody with those observed for R123 accumulation suggests that R123 efflux was mediated completely via P-gp. Furthermore, as MRK-16 is specific for the P-gpl isoform (Schinkel et al., 1991 (Schinkel et al., , 1993 , we conclude that R123 efflux is driven by P-gpl and not P-gp2, the mRNA for which was increased in HP-gp but not LP-gp cells. This result is consistent with that previously obtained by Ludescher et al. (1993) in B-cell chronic lymphocytic leukaemia. All MCF-7-derived cell clones had detectable MDR2 mRNA levels. The correlation between R123 accumulation and P-gpl levels as detected by MRK 16 in LP-gp and HP-gp cells indicates that there is no additional post-translational regulation of P-gp protein activity in HPgp in comparison with LP-gp cells.
As cPKC-a has been shown to play an important role in the post-translational regulation of P-gp activity (Yu et al., 1991; Ahmad and Glazer, 1993; Ahmad et al., 1994) , we analysed the level and distribution of PKC isozymes. In LPgp and HP-gp cells overall levels of PKC isozymes -o, -e, -C and -0, were similar. However, compared with MCF-7/WT cells the resistant cells expressed higher levels of cPKC-a and nPKC-0 and lower levels of nPKC-e and aPKC-C. The subcellular distribution of nPKC-e differed significantly between LP-gp, HP-gp and MCF-7/WT cells. The resistant cells possessed more nPKC-s in the membrane, and especially the nucleus, than wild-type cells. The fact that this distribution pattern locates nPKC-s more efficiently in close vicinity to P-gp is commensurate with a role for this enzyme in the post-translational regulation of P-gpl activity. This finding is consistent with the report of Slapak et al., 1993 , who observed a decrease in overall PKC activity in the cytosol of HL-60 cells with acquired vinblastine resistance and an increase in enzyme content in the membrane fractions compared with HL-60 WT cells. The results presented above show for the first time that PKC-0 is present in MCF-7/Dox cells and its subclones. Its absence in MCF-7/WT cells and expression in all three cell compartments, particularly in the membrane and nuclear fractions of LP-gp and HP-gp cells, render it another candidate for post-translational regulation of P-gp activity.
In conclusion we derived two cell lines from the widely used MCF-7/Dox cell line, of the same origin, which differed in their expression of both MDRI and MDR2 genes. This difference translated into an altered level of P-gpl expressed in the plasma membrane and a corresponding difference in the ability of each cell line to efflux R123. In both LP-gp and HP-gp cells the change in MDR2 mRNA over MCF-7/ WT cells was smaller than the increase in MDR2 gene copy number indicating a decreased transcription rate or mRNA stability or defective amplicon. post-translational increase in protein stability occurred. However, the identical 10-fold difference in R123 accumulation and P-gp levels between LP-gp and HP-gp cells indicated no change in post-translational regulation of protein activity. Analysis of PKC isozymes indicated a dramatic increase in nPKC-ax and nPKC-0 levels in both LPgp and HP-gp cells over MCF-7/WT cells. In comparison with MCF-7/WT cells nPKC-e expression was reduced overall in the resistant cell types, however the enzyme was distributed differently. More nPKC-s was located in the membrane and nucleus, which might indicate an important role for nPKC-s in the regulation of P-gpl activity.
Overall, the results highlight the complicated and multifaceted nature of regulation of the multidrug resistance phenotype in MCF-7/Dox cells. A better appreciation of how it is controlled will help to devise more efficacious therapies to overcome P-gp-mediated drug resistance.
